HGF and neoplasm: In the syngeneic MC38 model, treatment with either the anti-VEGF or the anti-HGF DARPin® molecules inhibited tumor growth but MP0250 gave significantly greater inhibition (Figure 3), the implication being that both growth factors contribute to the growth of this tumor and its vasculature.